These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


241 related items for PubMed ID: 11684961

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lymph node yield during radical prostatectomy does not impact rate of biochemical recurrence in patients with seminal vesicle invasion and node-negative disease.
    Badani KK, Reddy BN, Moskowitz EJ, Paulucci DJ, Beksac AT, Martini A, Whalen MJ, Skarecky DW, Huynh LM, Ahlering TE.
    Urol Oncol; 2018 Jun; 36(6):310.e1-310.e6. PubMed ID: 29625782
    [Abstract] [Full Text] [Related]

  • 5. Seminal vesicle invasion combined with extraprostatic extension is associated with higher frequency of biochemical recurrence and lymph node metastasis than seminal vesicle invasion alone: Proposal for further pT3 prostate cancer subclassification.
    Rehman A, El-Zaatari ZM, Han SH, Shen SS, Ayala AG, Miles B, Divatia MK, Ketcham MS, Chung BM, Rogers JT, Ro JY.
    Ann Diagn Pathol; 2020 Dec; 49():151611. PubMed ID: 32956915
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis.
    Egan AJ, Bostwick DG.
    Am J Surg Pathol; 1997 Dec; 21(12):1496-500. PubMed ID: 9414194
    [Abstract] [Full Text] [Related]

  • 8. Risk of prostate carcinoma death in patients with lymph node metastasis.
    Cheng L, Zincke H, Blute ML, Bergstralh EJ, Scherer B, Bostwick DG.
    Cancer; 2001 Jan 01; 91(1):66-73. PubMed ID: 11148561
    [Abstract] [Full Text] [Related]

  • 9. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
    Stock RG, Stone NN, Ianuzzi C, Unger P.
    Int J Radiat Oncol Biol Phys; 1995 Nov 01; 33(4):815-21. PubMed ID: 7591888
    [Abstract] [Full Text] [Related]

  • 10. Risk of lymph node metastases in pathological gleason score≤6 prostate adenocarcinoma: Analysis of institutional and population-based databases.
    Wenger H, Weiner AB, Razmaria A, Paner GP, Eggener SE.
    Urol Oncol; 2017 Jan 01; 35(1):31.e1-31.e6. PubMed ID: 27692833
    [Abstract] [Full Text] [Related]

  • 11. Radical prostatectomy findings in patients with locally aggressive Grade group 5 prostatic adenocarcinoma and negative limited or extended pelvic lymph node dissection.
    Mallikarjunappa SS, Osunkoya AO.
    Pathol Res Pract; 2023 Apr 01; 244():154415. PubMed ID: 36947981
    [Abstract] [Full Text] [Related]

  • 12. Limited value of perineural invasion in radical prostatectomy specimens as a predictor of biochemical recurrence in Japanese men with clinically localized prostate cancer.
    Miyake H, Sakai I, Harada K, Eto H, Hara I.
    Hinyokika Kiyo; 2005 Apr 01; 51(4):241-6. PubMed ID: 15912782
    [Abstract] [Full Text] [Related]

  • 13. Incidence of lymph node metastasis and its impact on long-term prognosis in clinically localized prostate cancer.
    Arai Y, Kanamaru H, Yoshimura K, Okubo K, Kamoto T, Yoshida O.
    Int J Urol; 1998 Sep 01; 5(5):459-65. PubMed ID: 9781435
    [Abstract] [Full Text] [Related]

  • 14. Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomy.
    Hansen J, Budäus L, Spethmann J, Schlomm T, Salomon G, Rink M, Haese A, Steuber T, Heinzer H, Huland H, Graefen M, Michl U.
    Urology; 2012 Oct 01; 80(4):877-82. PubMed ID: 22950996
    [Abstract] [Full Text] [Related]

  • 15. The incidence and significance of seminal vesicle invasion in patients with adenocarcinoma of the prostate.
    Mukamel E, deKernion JB, Hannah J, Smith RB, Skinner DG, Goodwin WE.
    Cancer; 1987 Apr 15; 59(8):1535-8. PubMed ID: 3815316
    [Abstract] [Full Text] [Related]

  • 16. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN, Stock RG, Parikh D, Yeghiayan P, Unger P.
    J Urol; 1998 Nov 15; 160(5):1722-6. PubMed ID: 9783940
    [Abstract] [Full Text] [Related]

  • 17. The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes.
    Mikel Hubanks J, Boorjian SA, Frank I, Gettman MT, Houston Thompson R, Rangel LJ, Bergstralh EJ, Jeffrey Karnes R.
    Urol Oncol; 2014 Jan 15; 32(1):26.e1-7. PubMed ID: 23395235
    [Abstract] [Full Text] [Related]

  • 18. Prediction of capsular perforation and seminal vesicle invasion in prostate cancer.
    Bostwick DG, Qian J, Bergstralh E, Dundore P, Dugan J, Myers RP, Oesterling JE.
    J Urol; 1996 Apr 15; 155(4):1361-7. PubMed ID: 8632575
    [Abstract] [Full Text] [Related]

  • 19. Periprostatic lymph node metastasis in prostate cancer and its clinical significance.
    Deng FM, Mendrinos SE, Das K, Melamed J.
    Histopathology; 2012 May 15; 60(6):1004-8. PubMed ID: 22373012
    [Abstract] [Full Text] [Related]

  • 20. Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer.
    Porcaro AB, de Luyk N, Corsi P, Sebben M, Tafuri A, Tamanini I, Processali T, Cerruto MA, Migliorini F, Brunelli M, Siracusano S, Artibani W.
    Tumori; 2017 May 12; 103(3):299-306. PubMed ID: 27716882
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.